Clinical Trial Evaluating the Safety and Efficacy of Chemoimmunotherapy Plus Short Course of Mek Inhibitor in First Line of Treatment of Metastatic Non Squamous Non Small Cell Lung Adenocarcinoma With PDL1 < 50 %.
Clinical trial NCT05937906 · RECRUITING
Trial details
- NCT number
- NCT05937906
- Sponsor
- Centre Georges Francois Leclerc
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-07
- Primary completion
- 2028-07-25
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.